Search

Learn about how the immunotherapies ipilimumab (Yervoy®) and nivolumab (Opdivo®) could provide a new option for patients with metastatic renal cell carcinoma.

… Monday, April 16, 2018 Summary The combination of two immunotherapies outperformed a targeted therapy with regard to overall survival in a phase III study of untreated patients with metastatic renal cell carcinoma (a type of kidney cancer ). Update: On April 16, 2018, the FDA approved the combination

A generous gift provides a major boost to translational research at MSK.

… Friday, January 1, 2021 Dear MSK Community, Breakthrough cancer discovery can start anywhere: a patient with a unique case, a researcher with a hunch, or an unexpected result that connects seemingly disparate findings. An investigation into a new treatment can begin with the patient, move to the lab,

Physician-in-Chief Lisa M. DeAngelis joins healthcare experts during the AACR Virtual Meeting: COVID-19 and Cancer to discuss how to safely bring patients to the clinic so they can receive vital cancer screenings and care.

… Friday, July 17, 2020 Thousands of oncology experts from around the world will tune in virtually July 20-22 for the American Association for Cancer Research (AACR) Virtual Meeting: COVID-19 and Cancer . This special AACR conference will focus on emerging data in basic, clinical, and epidemiologic research

Scientists came to give talks and celebrate the achievements that the program has made under the leadership of Kathryn Anderson.

… Wednesday, November 21, 2018 A female scientist speaking Ruth Lehmann, Director of the Skirball Institute of Biomolecular Medicine at NYU Langone Health A male scientist speaking Siegfried Roth, a professor at the Institute for Zoology Biocenter at the University of Cologne, in Germany A female scientist

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).

… Thursday, June 3, 2021 New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC). The phase

Learn about the breast cancer type called ductal carcinoma in situ (DCIS) and how doctors decide on the best treatment for each person.

… Tuesday, October 12, 2021 Summary Ductal carcinoma in situ (DCIS) makes up approximately 20% of newly diagnosed breast cancers. But patients are often confused about DCIS, what it means, and what to do about it. We asked MSK surgeon Andrea Barrio to provide some insight into the disease and its treatments

While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.

… Friday, January 16, 2026 There’s good news about surviving stage 4 cancer — meaning cancer that has spread to other parts of the body — according to the new  Cancer Facts and Figures report from the American Cancer Society. In a sign of remarkable progress over the past two decades, more than one-third

As 2019 comes to an end, take a moment to reflect on the science stories that made the year one to remember.

… Monday, December 16, 2019 Many medical breakthroughs blossom from the seeds of basic science research. This past year, Memorial Sloan Kettering scientists made fundamental discoveries in several basic science fields, including cell biology, molecular biology, developmental biology, and more. Much of

The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed 16 students to our annual Summer Undergraduate Research Program.

… Tuesday, June 14, 2016 Sixteen undergraduate students arrived on June 6, 2016, to begin their Summer Undergraduate Research Program (SURP) under the auspices of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. They were greeted by GSK Associate Dean Linda Burnley and SURP faculty

With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.

… Wednesday, March 9, 2022 Every year, thousands of biochemistry majors and medical students around the world learn to memorize the major biochemical pathways that allow cells to function. How these 10 or so pathways are described in textbooks hasn’t changed much since the early 20th century, when they